Protein Prp45, the yeast ortholog of the human transcription coregulator SNW1/SKIP, has been previously associated only with the regulation of pre-mRNA splicing. However, our laboratory found that protein Prp45 genetically interacts not only with the proteins involved in pre-mRNA splicing, but also with factors important for transcription elongation and with chromatin modifying enzymes. Our data and the information about the human ortholog SNW1/SKIP suggest that Prp45 could serve as a regulator coupling splicing, transcription and chromatin state in S. cerevisiae. The main aim of this diploma thesis was to find out whether the protein Prp45, which is essential for cotranscriptional assembly of the spliceosome, affects posttranslational modifications of chromatin on transcribed genes. Using chromatin immunoprecipitation, the influence of prp45(1-169) mutation on trimethylation of histone H3 at lysine 4 and acetylation of histone H3 at lysines 9, 14 and 18 on transcriptionally active genes was not confirmed. The other aim was to analyse the behavior of cells synchronized by α-factor by using flow cytometry. According to our results, prp45(1-169) mutation leads to the prolongation of the cell cycle. For the purpose of monitoring the dynamics of nucleosomes in S. cerevisiae strains, the system of...

A principal característica do diabetes mellitus (DM) é a perda da homeostasia glicêmica. O músculo esquelético desempenha papel chave e a adequada expressão do transportador de glicose GLUT4 (gene Slc2a4) é fundamental. Regulações epigenéticas do Slc2a4, como acetilação/trimetilação de histona H3, nunca foram investigadas no DM; e o resveratrol, sugerido como sensibilizador da insulina, poderia modular essas regulações, pois ativa a desacetilase sirtuína 1 (SIRT1). O objetivo foi avaliar em modelos de DM o efeito do tratamento com resveratrol sobre a homeostasia glicêmica, a expressão de Slc2a4/GLUT4 em músculo esquelético, a regulação epigenética do Slc2a4, e a possível participação da SIRT1. Os dados revelam a ocorrência de regulações epigenéticas no gene Slc2a4 em músculo de animais diabéticos e mostra que o tratamento com insulina ou resveratrol modula algumas dessas alterações, melhorando o controle glicêmico. Esses resultados apoiam o resveratrol como um sensibilizador da insulina, e constroem bases para o desenvolvimento de terapias epigenéticas para o DM. / The main characteristic of diabetes mellitus (DM) is the loss of glycemic homeostasis. The skeletal muscle plays a key role and the maintenance expression of the GLUT4 glucose transporter (encoded by the Slc2a4 gene) is fundamental. Epigenetic regulations of Slc2a4, such as histone H3 acetylation/trimethylation, have never been investigated in DM; and resveratrol, suggested as an insulin sensitizer, could modulate these regulations, as it is an activator of the deacetylase sirtuin 1 (SIRT1). The aim was to evaluate in skeletal muscle of diabetic animals the effect of resveratrol treatment on glycemic homeostasis, Slc2a4/GLUT4 expression in skeletal muscle, the epigenetic regulation of Slc2a4, and the possible participation of SIRT1. The data reveals the occurrence of epigenetic regulation in the Slc2a4 gene in muscle of diabetic animals and the insulin or resveratrol treatment modulates some of these changes, improving glycemic control. These results support resveratrol as an insulin sensitizer, and build bases for the development of epigenetic therapies for DM.